yyloh21

yyloh21 | Joined since 2016-07-12

Investing Experience -
Risk Profile -

Followers

0

Following

0

Blog Posts

0

Threads

4

Blogs

Threads

Portfolio

Follower

Following

Summary
Total comments
4
Past 30 days
0
Past 7 days
0
Today
0

User Comments
Stock

2016-08-24 16:48 | Report Abuse

i wonder who is buying 100 shares @0.34 everytime it is pushed to 0.335, i think someone will be pissed by it. :-)

Stock

2016-07-21 17:36 | Report Abuse

bought with avg 1.91. Ready to enter somemore tomorrow.

Stock

2016-07-14 17:00 | Report Abuse

The coming conf is only announcing the first 2 trials results. Still there is phase 3. Therefore, beware when you rush in to buy.

Stock

2016-07-14 16:58 | Report Abuse

Phase 3 clinical trials are currently underway with TauRx’s second-generation tau aggregation inhibitor, LMTX®. The Phase 3 programme comprises two clinical trials in Alzheimer’s disease and a further trial in the neurodegenerative orphan indication behavioural variant frontotemporal dementia.

The trials are fully recruited and results are expected in Q3 2016.

TRX-005 TRX-015